We are live on ! Find out more
NVCT icon

Nuvectis Pharma

36 hedge funds and large institutions have $12.6M invested in Nuvectis Pharma in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

519% more capital inflows, than outflows

Capital inflows: $2.42M | Capital outflows: $392K

167% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 6

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

9% more funds holding

Funds holding: 33 → 36 (+3)

1.32% more ownership

Funds ownership: 7.41% → 8.73% (+1.3%)

Holders
36
Holders Change
+3
Holders Change %
+9.09%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
16
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NVCT Hedge Fund Activity: Q4 2023 in Review

36 of the 6,879 institutional investors tracked by Wall St. Rank reported a position in Nuvectis Pharma (NVCT) for Q4 2023, worth a combined $12.6M — down 23% from $16.5M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NVCT positions and 2 closed out — a net gain of 3 holders — while 16 added to existing stakes and 6 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $303K. The largest seller was Moran Wealth Management, exiting entirely with an estimated $215K sold.

  • 36 institutional investors held Nuvectis Pharma (NVCT) as of Q4 2023, up from 33 in Q3 2023.
  • Funds reported $12.6M of Nuvectis Pharma stock for Q4 2023, down 23% quarter-over-quarter.
  • 5 funds opened new Nuvectis Pharma positions in Q4 2023 and 2 closed out, a net change of +3 holders.
  • The largest Nuvectis Pharma buyer in Q4 2023 was Millennium Management, an estimated $303K added.
  • The largest Nuvectis Pharma seller in Q4 2023 was Moran Wealth Management, an estimated $215K sold.

Based on aggregated 13F filings for Q4 2023.